Grifols ( Grifols )


Grifols's picture

Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. We accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.

Grifols press release, blog etc

12/04/2017 - 05:59 Grifols Misterium Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation
11/22/2017 - 08:47 Grifols inaugurates a new plant of the Diagnostic Division in Brazil to manufacture storage and collection bags for blood components
11/17/2017 - 11:51 FDA approval of genetic test for alpha-1 deficiency and EMA approval of fibrin sealant
11/16/2017 - 06:42 Grifols one of 500 best companies in the world to work for, according to Forbes Magazine
11/02/2017 - 05:47 Grifols increases its revenues by 10% to Euros 3,250 million and grows net profit by 6.3% to reach Euros 432 million
09/22/2017 - 05:13 Prolastin
09/21/2017 - 07:15 Grifols research lines in Alzheimer's move forward with both treatment and prevention
08/22/2017 - 07:28 Grifols Phocus Rx Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces
08/01/2017 - 06:46 Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol
07/09/2017 - 02:37 Winner of the 2017 SPIN Award Program
07/05/2017 - 02:03 Grifols opens new lines of research with the acquisition of a 44% stake in GigaGen for USD 35 million
06/29/2017 - 15:35 Grifols voluntarily discloses transfers of value
06/27/2017 - 13:35 Araclon Biotech initiates phase II clinical trials of its Alzheimer's vaccine
06/26/2017 - 15:36 Grifols Awards One Million Dollar Grant to Support the Alpha-1 Foundation's John W. Walsh Research Fund
06/23/2017 - 14:47 Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples
06/12/2017 - 03:32 Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement
06/05/2017 - 14:37 Grifols' physiological saline solution produced in its Murcia facility receives U.S. FDA approval
05/26/2017 - 08:28 Grifols allocates Euros 218 million to dividends, with a compound annual growth rate of 16% over the last 4 years